Skip to main content

Peripheral Neuralgia

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Nalu Medical
Nalu MedicalCA - Carlsbad
2 programs
Nalu Neurostimulation System for PNSN/A1 trial
Nalu Neurostimulation System for PNSN/A1 trial
Active Trials
NCT05870124Active Not Recruiting185Est. Dec 2027
NCT05287373Active Not Recruiting89Est. Sep 2026

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
Nalu MedicalNalu Neurostimulation System for PNS
Nalu MedicalNalu Neurostimulation System for PNS

Clinical Trials (2)

Total enrollment: 274 patients across 2 trials

NCT05870124Nalu MedicalNalu Neurostimulation System for PNS

Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)

Start: Apr 2023Est. completion: Dec 2027185 patients
N/AActive Not Recruiting
NCT05287373Nalu MedicalNalu Neurostimulation System for PNS

Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain

Start: Feb 2022Est. completion: Sep 202689 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.